Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity

T S Gerashchenko; M V Zavyalova; E V Denisov; N V Krakhmal; D N Pautova; N V Litviakov; S V Vtorushin; N V Cherdyntseva; V M Perelmuter

Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity

Acta Naturae. 2017 Jan-Mar;9(1):56-67.

Authors

T S Gerashchenko^{1

2}, M V Zavyalova^{1

2

3}, E V Denisov^{1

2}, N V Krakhmal^{1

3}, D N Pautova², N V Litviakov^{1

2}, S V Vtorushin^{1

3}, N V Cherdyntseva^{1

2}, V M Perelmuter^{1

3}

Affiliations

¹ Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia.
² Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia.
³ Siberian State Medical University, Moskovsky trakt 2, Tomsk, 634050, Russia.

PMID: 28461975
PMCID: PMC5406661

Abstract

Breast cancer (BC) demonstrates considerable intratumoral morphological heterogeneity. The aim of this work was to evaluate the relationship among different morphological structures, the rate of metastasis, and efficacy of neoadjuvant chemotherapy (NAC) in NAC-treated (n = 427) and NAC-naïve (n = 249) BC patients. We also studied the involvement of an epithelial-mesenchymal transition (EMT) in the development of the intratumoral morphological heterogeneity of BC. We found a significant association between the intratumoral morphological heterogeneity and the rate of BC metastasis and response to NAC, which, in most cases, correlated with the presence of alveolar and trabecular structures. In particular, the rate of lymph node metastasis in tumors containing alveolar and trabecular structures was higher compared to that in tumors lacking such structures. NAC-treated patients with alveolar and trabecular structures had a high distant metastasis rate and a low metastasis-free survival rate. Furthermore, alveolar and trabecular structures were found to be associated with a lack of response to NAC. Interestingly, the association between alveolar structures and a high distant metastasis rate was found only in NAC-unresponsive patients, whereas the association between trabecular structures and an increased distant metastasis was revealed in responders. Alveolar structures were associated with chemoresistance only in patients with lymph node metastases, whereas trabecular structures were associated with chemoresistance only in patients without lymph node metastases. In general, increased intratumoral morphological diversity correlated with considerable chemoresistance and a high metastasis rate of BC. We found variable expressions of epithelial (EPCAM and CDH1) and mesenchymal (ITGA5, ITGB5, CDH2, CDH11, TGFb2, ZEB1, MMP2, DCN, MST1R) markers and, thus, different EMT manifestations in different morphological structures. Therefore, intratumoral morphological heterogeneity of BC may serve as an indicator of the metastatic potential and tumor chemosensitivity.

Keywords: breast cancer; chemotherapy; epithelial-mesenchymal transition; intratumoral heterogeneity; invasion; metastasis.